Dimensional Fund Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $374M | Sell |
1,648,450
-4,034
| -0.2% | -$718K | 0.07% | 294 |
|
|
2026
Q1 | $285M | Buy |
1,652,484
+210,260
| +15% | +$39M | 0.06% | 367 |
|
|
2025
Q4 | $288M | Buy |
1,442,224
+311,319
| +28% | +$56.5M | 0.06% | 367 |
|
|
2025
Q3 | $177M | Buy |
1,130,905
+120,207
| +12% | +$19.1M | 0.04% | 624 |
|
|
2025
Q2 | $153M | Buy |
1,010,698
+148,444
| +17% | +$19.8M | 0.04% | 688 |
|
|
2025
Q1 | $130M | Buy |
862,254
+198,750
| +30% | +$33.3M | 0.03% | 762 |
|
|
2024
Q4 | $122M | Buy |
663,504
+135,986
| +26% | +$26.2M | 0.03% | 864 |
|
|
2024
Q3 | $104M | Sell |
527,518
-33,557
| -6% | -$6.97M | 0.03% | 1002 |
|
|
2024
Q2 | $116M | Buy |
561,075
+93,682
| +20% | +$21.2M | 0.03% | 836 |
|
|
2024
Q1 | $127M | Sell |
467,393
-14,553
| -3% | -$3.48M | 0.03% | 766 |
|
|
2023
Q4 | $114M | Buy |
481,946
+80,698
| +20% | +$15.9M | 0.03% | 796 |
|
|
2023
Q3 | $78.6M | Buy |
401,248
+16,122
| +4% | +$3.31M | 0.03% | 999 |
|
|
2023
Q2 | $81M | Buy |
385,126
+31,705
| +9% | +$6.31M | 0.03% | 988 |
|
|
2023
Q1 | $71.3M | Buy |
+353,421
| New | +$80.1M | 0.02% | 1060 |
|
|
2022
Q3 | $56.9M | Buy |
289,205
+23,943
| +9% | +$5.17M | 0.02% | 1115 |
|
|
2022
Q2 | $56.8M | Sell |
265,262
-7,103
| -3% | -$1.74M | 0.02% | 1192 |
|
|
2022
Q1 | $77.3M | Sell |
272,365
-13,837
| -5% | -$4.27M | 0.02% | 1051 |
|
|
2021
Q4 | $108M | Sell |
286,202
-85,711
| -23% | -$33.3M | 0.03% | 819 |
|
|
2021
Q3 | $153M | Sell |
371,913
-18,444
| -5% | -$7.66M | 0.05% | 509 |
|
|
2021
Q2 | $144M | Sell |
390,357
-30,096
| -7% | -$10M | 0.05% | 552 |
|
|
2021
Q1 | $122M | Sell |
420,453
-11,491
| -3% | -$3.19M | 0.04% | 655 |
|
|
2020
Q4 | $108M | Sell |
431,944
-2,289
| -0.5% | -$545K | 0.04% | 676 |
|
|
2020
Q3 | $98.3M | Sell |
434,233
-7,125
| -2% | -$1.48M | 0.04% | 592 |
|
|
2020
Q2 | $76.9M | Sell |
441,358
-31,778
| -7% | -$5.07M | 0.03% | 780 |
|
|
2020
Q1 | $59.7M | Sell |
473,136
-12,536
| -3% | -$1.88M | 0.03% | 860 |
|
|
2019
Q4 | $74.2M | Sell |
485,672
-6,971
| -1% | -$965K | 0.03% | 1023 |
|
|
2019
Q3 | $65.2M | Buy |
492,643
+7,106
| +1% | +$953K | 0.03% | 1114 |
|
|
2019
Q2 | $68.9M | Sell |
485,537
-22,776
| -4% | -$3.09M | 0.03% | 1068 |
|
|
2019
Q1 | $73.8M | Buy |
508,313
+2,978
| +0.6% | +$391K | 0.03% | 953 |
|
|
2018
Q4 | $57.2M | Sell |
505,335
-12,294
| -2% | -$1.54M | 0.03% | 1075 |
|
|
2018
Q3 | $69.6M | Sell |
517,629
-732
| -0.1% | -$90.3K | 0.03% | 1075 |
|
|
2018
Q2 | $58.2M | Sell |
518,361
-6,651
| -1% | -$719K | 0.02% | 1247 |
|
|
2018
Q1 | $56M | Sell |
525,012
-12,733
| -2% | -$1.37M | 0.02% | 1213 |
|
|
2017
Q4 | $58.9M | Buy |
537,745
+757
| +0.1% | +$82.4K | 0.02% | 1168 |
|
|
2017
Q3 | $58M | Sell |
536,988
-10,869
| -2% | -$1.12M | 0.03% | 1120 |
|
|
2017
Q2 | $55.4M | Sell |
547,857
-88,083
| -14% | -$8.11M | 0.03% | 1115 |
|
|
2017
Q1 | $57.2M | Sell |
635,940
-5,360
| -0.8% | -$455K | 0.03% | 1033 |
|
|
2016
Q4 | $48.9M | Sell |
641,300
-35,729
| -5% | -$2.71M | 0.02% | 1147 |
|
|
2016
Q3 | $56.4M | Sell |
677,029
-199,434
| -23% | -$16.7M | 0.03% | 915 |
|
|
2016
Q2 | $72.3M | Sell |
876,463
-2,282
| -0.3% | -$188K | 0.04% | 611 |
|
|
2016
Q1 | $66.7M | Buy |
878,745
+4,973
| +0.6% | +$368K | 0.04% | 638 |
|
|
2015
Q4 | $70.2M | Sell |
873,772
-12,834
| -1% | -$926K | 0.04% | 570 |
|
|
2015
Q3 | $56.3M | Buy |
886,606
+513
| +0.1% | +$36.8K | 0.04% | 699 |
|
|
2015
Q2 | $62.3M | Sell |
886,093
-49,121
| -5% | -$3.63M | 0.04% | 660 |
|
|
2015
Q1 | $74.2M | Buy |
935,214
+6,596
| +0.7% | +$487K | 0.05% | 520 |
|
|
2014
Q4 | $59.1M | Buy |
928,618
+35,805
| +4% | +$2.24M | 0.04% | 623 |
|
|
2014
Q3 | $53.3M | Buy |
892,813
+5,060
| +0.6% | +$290K | 0.04% | 628 |
|
|
2014
Q2 | $47.5M | Buy |
887,753
+153,644
| +21% | +$8.43M | 0.03% | 756 |
|
|
2014
Q1 | $44.3M | Buy |
734,109
+45,972
| +7% | +$2.68M | 0.03% | 744 |
|
|
2013
Q4 | $36.5M | Buy |
688,137
+23,488
| +4% | +$1.18M | 0.03% | 873 |
|
|
2013
Q3 | $30.7M | Buy |
664,649
+25,502
| +4% | +$1.17M | 0.03% | 929 |
|
|
2013
Q2 | $26.2M | Buy |
+639,147
| New | +$27.4M | 0.02% | 975 |
|
Other funds holding CRL
AI
Dimensional Fund Advisors's CRL Position: Q2 2026 in Review
Dimensional Fund Advisors reduced its Charles River Laboratories (CRL) stake by 0.24% in Q2 2026, selling an estimated $718K and leaving 1,648,450 shares worth $374M. The position accounts for 0.07% of the portfolio, ranked #294.
Dimensional Fund Advisors first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Dimensional Fund Advisors held 1,648,450 shares of Charles River Laboratories worth $374M as of Q2 2026.
- Dimensional Fund Advisors sold 4,034 Charles River Laboratories shares in Q2 2026, an estimated $718K.
- Charles River Laboratories made up 0.07% of Dimensional Fund Advisors's portfolio in Q2 2026, its #294 holding.
- Dimensional Fund Advisors first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
- 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.